Want to see CTSO full AI Analyst Report?
Cytosorbents (CTSO) Q2 2025 Earnings Report
CTSO Q2 2025 EPS Results
- Actual EPS
- $0.60
- Consensus EPS
- -$1.13
- Beat/Miss
- Beat by +$1.73
- One Year Ago EPS
- -$1.60
CTSO Q2 2025 Revenue Results
- Actual Revenue
- $9.62M
- Expected Revenue
- $9.23M
- Beat/Miss
- Beat by +$382.00K
- YoY Revenue Growth
- -2.81%
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 08/07/2025
- Time
- After Close
- Conference Call
- Thursday, August 7, 2025
CTSO Upcoming Earnings
Cytosorbents's next earnings date is estimated for November 12, 2026, based on past reporting schedules.
Q2 2025 Earnings Call Audio
CTSO Q2 2025 Earnings Call
0:00 / 0:00
Q2 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
CTSO Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 12, 2026 | 2026 (Q3) | -0.90- | -0.8 | ― | ― |
| Aug 06, 2026 | 2026 (Q2) | -0.90-1.40 | 0.6 | -333.33% (-2.00) | |
| May 13, 2026 | 2026 (Q1) | -1.10-1.00 | -0.4 | -150.00% (-0.60) | |
| Mar 25, 2026 | 2025 (Q4) | -1.00-1.80 | -2.8 | 35.71% (+1.00) | |
| Nov 13, 2025 | 2025 (Q3) | -0.80-0.80 | -0.8 | 0.00% (+0.00) | |
| Aug 07, 2025 | 2025 (Q2) | -1.130.60 | -1.6 | 137.50% (+2.20) | |
| May 14, 2025 | 2025 (Q1) | ―-0.02 | -2.4 | 99.17% (+2.38) | |
| Mar 31, 2025 | 2024 (Q4) | -1.40-0.40 | -2.4 | 83.33% (+2.00) | |
| Nov 07, 2024 | 2024 (Q3) | -1.27-0.80 | -4.2 | 80.95% (+3.40) | |
| Aug 13, 2024 | 2024 (Q2) | -1.95-1.60 | -2.8 | 42.86% (+1.20) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
